[go: up one dir, main page]

PE20151882A1 - Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos - Google Patents

Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos

Info

Publication number
PE20151882A1
PE20151882A1 PE2015001944A PE2015001944A PE20151882A1 PE 20151882 A1 PE20151882 A1 PE 20151882A1 PE 2015001944 A PE2015001944 A PE 2015001944A PE 2015001944 A PE2015001944 A PE 2015001944A PE 20151882 A1 PE20151882 A1 PE 20151882A1
Authority
PE
Peru
Prior art keywords
lipids
compositions containing
fatty globules
nutritional compositions
containing structured
Prior art date
Application number
PE2015001944A
Other languages
English (en)
Inventor
John D Alvey
Juan M Gonzalez
Dattatreya Banavara
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/794,151 external-priority patent/US20140255537A1/en
Priority claimed from US13/794,270 external-priority patent/US9980506B2/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20151882A1 publication Critical patent/PE20151882A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UNA COMPOSICION NUTRICIONAL QUE COMPRENDE: A) UNA FUENTE DE CARBOHIDRATOS; B) UNA FUENTE DE PROTEINA; Y C) UNA FUENTE DE LIPIDOS QUE COMPRENDE GLOBULOS GRASOS DE LA LECHE FORMADOS A PARTIR DE UNA FRACCION ENRIQUECIDA DE LIPIDOS DERIVADOS DE LA LECHE QUE CONTIENE ACIDOS GRASOS, FOSFOLIPIDOS, COLESTEROL, ENTRE OTROS. TAMBIEN SE REFIERE A METODOS DE APOYO A LA DIGESTION DE LOS LIPIDOS EN UN SUJETO PEDIATRICO, PROPORCIONANDO UNA COMPOSICION NUTRITIVA QUE COMPRENDE UNA FRACCION ENRIQUECIDA DE LIPIDOS QUE TIENE GLOBULOS GRASOS ESTRUCTURADOS QUE SON MAS ACCESIBLES A LAS LIPASAS
PE2015001944A 2013-03-11 2014-02-21 Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos PE20151882A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/794,151 US20140255537A1 (en) 2013-03-11 2013-03-11 Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
US13/794,270 US9980506B2 (en) 2013-03-11 2013-03-11 Nutritional compositions containing structured fat globules and uses thereof
US13/833,765 US9661874B2 (en) 2013-03-11 2013-03-15 Nutritional compositions containing structured fat globules and uses thereof

Publications (1)

Publication Number Publication Date
PE20151882A1 true PE20151882A1 (es) 2016-01-17

Family

ID=50240025

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001944A PE20151882A1 (es) 2013-03-11 2014-02-21 Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos

Country Status (14)

Country Link
US (1) US9661874B2 (es)
EP (1) EP2983520A1 (es)
CN (2) CN105188412A (es)
AU (2) AU2014228621B2 (es)
BR (1) BR112015018479A2 (es)
CA (1) CA2904268A1 (es)
HK (1) HK1219026A1 (es)
MX (1) MX370009B (es)
MY (1) MY172796A (es)
PE (1) PE20151882A1 (es)
PH (1) PH12015501853A1 (es)
RU (1) RU2015140733A (es)
SG (1) SG11201505531YA (es)
WO (1) WO2014143523A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY205872A (en) 2009-04-29 2024-11-18 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising omega-3 fatty acids
US20120100208A1 (en) 2009-04-29 2012-04-26 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
AU2010260129B2 (en) 2009-06-15 2014-05-29 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels
BR112012006692B8 (pt) 2009-09-23 2021-05-25 Amarin Corp Plc composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato
NZ727980A (en) 2010-11-29 2018-08-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
PT4338805T (pt) 2012-06-29 2025-09-02 Amarin Pharmaceuticals Ie Ltd Éster etílico do ácido eicosapentanoico para utilização na redução do risco de enfarte do miocárdio não fatal num indivíduo em terapia com estatina
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
BR112017008747A2 (pt) * 2014-11-07 2017-12-19 Mjn Us Holdings Llc composições nutricionais contendo um prebiótico e lactoferrina e seus usos
JP6446265B2 (ja) * 2014-12-26 2018-12-26 花王株式会社 固形状組成物
EP3087850A1 (en) * 2015-03-16 2016-11-02 N.V. Nutricia Two-step emulsification process for preparing infant formula
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
DK3874959T3 (da) * 2016-12-09 2024-08-05 Nutricia Nv Ernæringsmæssig sammensætning til anvendelse til forbedring af kognitiv ydeevne og/eller forbedring af kognitiv svækkelse
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
PL4056176T3 (pl) 2018-09-24 2024-08-26 Amarin Pharmaceuticals Ireland Limited Sposoby zmniejszania ryzyka zdarzeń krążeniowo-naczyniowych u osobnika
KR20220122616A (ko) 2019-11-12 2022-09-02 애머린 파마슈티칼스 아일랜드 리미티드 심방 세동 및/또는 심방 조동을 갖는 대상체에서 심혈관 사건의 위험을 감소시키는 방법
CN114945284A (zh) * 2019-12-16 2022-08-26 嘉吉公司 营养组合物和其制备方法
CA3199688A1 (en) * 2020-11-27 2022-06-02 Nikolaj DRACHMANN Novel cholesterol-enriched milk lipid composition suitable for infant nutrition, method of production, and nutritional compositions comprising the milk lipid composition
EP4326244A4 (en) 2021-04-21 2025-03-19 Amarin Pharmaceuticals Ireland Limited METHODS TO REDUCE THE RISK OF HEART FAILURE
WO2023141658A1 (en) * 2022-01-24 2023-07-27 Nutraceutical Corporation Multiple nutrient liposomal supplement and methods of manufacturing the same
EP4661698A1 (en) 2023-02-06 2025-12-17 Nutricia Early Life Nutrition (Shanghai) Co., Ltd. Preserving vitamin in a nutritional composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3488327B2 (ja) 1995-12-21 2004-01-19 よつ葉乳業株式会社 牛乳脂肪球膜含有画分の製造法
US6475984B2 (en) 1999-04-29 2002-11-05 The Nemours Foundation Administration of leptin
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
CN101316521B (zh) 2005-04-28 2014-06-25 恩兹默泰克有限公司 极性脂质混合物、其制备和应用
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US20080003329A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
HRP20120929T1 (hr) 2008-09-02 2012-12-31 N.V. Nutricia Prehrambeni pripravci koji sadrže obložene lipidne globule
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
EP2258216A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258218A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
AU2010329990B2 (en) * 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
WO2011108918A1 (en) 2010-03-04 2011-09-09 N.V. Nutricia Modulation of post-prandial fat absorption
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
US20110293784A1 (en) * 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
MX2012012142A (es) 2010-05-28 2012-11-21 Mead Johnson Nutrition Co Composiciones nutricionales.
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
US20120269929A1 (en) 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
EP2638810A1 (en) 2012-03-15 2013-09-18 N.V. Nutricia Process for preparing infant formula
US20140199265A1 (en) 2013-01-11 2014-07-17 Mead Johnson Nutrition Company Nutritional compositions containing a neurologic component and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof

Also Published As

Publication number Publication date
BR112015018479A2 (pt) 2017-07-18
PH12015501853A1 (en) 2015-12-07
WO2014143523A1 (en) 2014-09-18
CN109043513A (zh) 2018-12-21
MX370009B (es) 2019-11-28
MX2015011541A (es) 2016-02-05
CA2904268A1 (en) 2014-09-18
AU2017203491A1 (en) 2017-06-15
EP2983520A1 (en) 2016-02-17
MY172796A (en) 2019-12-12
US9661874B2 (en) 2017-05-30
US20140255539A1 (en) 2014-09-11
HK1219026A1 (zh) 2017-03-24
AU2014228621A1 (en) 2015-08-06
RU2015140733A (ru) 2017-04-13
SG11201505531YA (en) 2015-08-28
AU2017203491B2 (en) 2018-05-24
CN105188412A (zh) 2015-12-23
AU2014228621B2 (en) 2017-05-25

Similar Documents

Publication Publication Date Title
PE20151882A1 (es) Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos
AR095083A1 (es) Composiciones nutricionales que contienen una fracción lipídica enriquecida y método asociado a la administración de una nutrición lípida
AR097110A1 (es) Composiciones nutricionales que contienen una combinación sinérgica y usos de las mismas
MX372724B (es) Formulaciones de acido eicosapentaenoico (epa).
AR095084A1 (es) Composiciones nutricionales que contienen glóbulos de grasa estructurados y método asociado a la promoción de la digestión de lípidos
PE20151765A1 (es) Formulas a base de hidrolizado de aminoacido y proteina con un sistema estable de emulsion
MX2013014428A (es) Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche.
BR112012023267A2 (pt) Método para alterar a composição dos ácidos graxos da membrana cerebral, método para aperfeiçoar o desempenho cognitivo em um indivíduo humano e uso de uma composição
MX386820B (es) Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología.
AR105144A1 (es) Composiciones nutricionales y métodos para promover el desarrollo cognitivo
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
MY167583A (en) Infant formula with high sn-2 palmitate and oligofructose
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
ECSP13012807A (es) Composición que comprende proteínas de leche termolábiles y proceso para para preparar la misma
ECSP14000502A (es) Composiciones nutricionales de caseína-suero parcialmente hidrolizadas para reducir la aparición de alergias
CO7310519A2 (es) Enriquecedor para un sucedáneo de la leche materna
MX2016008495A (es) Composicion nutricional pediatrica con peptidos lacteos para un crecimiento y desarrollo saludable.
MX2015007082A (es) Métodos de administración de composiciones que comprenden ácido docosapentanoico.
EA201290706A1 (ru) Продукт - заменитель молока
WO2015095570A3 (en) Nutritional composition comprising hydrolyzed protein
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
TH178071A (th) องค์ประกอบทางโภชนาการที่มีส่วนแยกที่ถูกทำให้มีไลปิดมากขึ้นและการใช้ของมัน
UA95202U (xx) Біологічно активна добавка "фосфомол-dv"
PL401895A1 (pl) Zastosowanie preparatu fosfolipidowego z zóltka jaj
TH156885A (th) การปรับการดูดซึมไขมันหลังมื้ออาหาร

Legal Events

Date Code Title Description
FA Abandonment or withdrawal